Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00012302
DRKS00012302
Completed
未知

Examination of neuronal and metabolic effects of long-term transcutaneous vagus nerve stimulation in obese adult males - MetVNS

niversitätsklinik zu Lübeck Medizinische Klinik 1 - Klinik für Neurologie0 sites40 target enrollmentJune 14, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsObesityE66

Overview

Phase
未知
Intervention
Not specified
Conditions
Obesity
Sponsor
niversitätsklinik zu Lübeck Medizinische Klinik 1 - Klinik für Neurologie
Enrollment
40
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2017
End Date
November 25, 2018
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversitätsklinik zu Lübeck Medizinische Klinik 1 - Klinik für Neurologie

Eligibility Criteria

Inclusion Criteria

  • •BMI\>28kg/m2
  • •normal sleep rhythm
  • •18\-45 years
  • •fluent in German
  • •no transcutaneous Vagus nerve stimulation before
  • •last blood samples taken \> 4weeks

Exclusion Criteria

  • •left handed;
  • •vegetarian or vegan diet;
  • •Food allergies;
  • •smoker/ drug user;
  • •on a diet during the trial;
  • •sleeping disorders/ shift work;
  • •regular drug ingestion;
  • •psychological or physiological disease;
  • •acute stressful Situation;
  • •non\-removable magnetic Implants;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Metabolic and Neurobiological changes after Continuous Positive Airway Pressure treatment for Obstructive Sleep ApneaObstructive Sleep ApneaRespiratory - Sleep apnoea
ACTRN12608000301369Sydney South West Area Health Service60
Not yet recruiting
Not Applicable
Stress, its associated risk factors, and effect of slow-paced breathing in post COVID -19 subjectsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/09/036101Simran Kaur
Recruiting
Phase 2
Influence on brain perfusion and metabolism through pharmacologic agentsmultiple sclerosis10012303
NL-OMON29781niversitair Medisch Centrum Groningen30
Active, not recruiting
Not Applicable
Influence on brain perfusion and metabolism through pharmacologic agentsMultiple SclerosisMedDRA version: 8.1Level: PTClassification code 10028245Term: Multiple sclerosis
EUCTR2006-004318-42-NLDepartment of Neurology UMCG
Active, not recruiting
Not Applicable
Clinical, morphological and biochemical effects of antioxidant treatment of patients with chronic hepatitis C.Chronic hepatitis C with moderate to severe liver damage.The patients should not be suitable for standard medical treatment or refuse standard medical treatment for personal reasons.
EUCTR2005-002455-41-SEKarolinska Institutet30